Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 59 entries
Sorted by: Best Match Show Resources per page
Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?.

PLoS neglected tropical diseases

Hsieh MH, Brotherton JM, Siddiqui AA.
PMID: 26020953
PLoS Negl Trop Dis. 2015 May 28;9(5):e0003598. doi: 10.1371/journal.pntd.0003598. eCollection 2015 May.

No abstract available.

Cite
Hsieh MH, Brotherton JM, Siddiqui AA. Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?. PLoS Negl Trop Dis. 2015;9(5):e0003598doi: 10.1371/journal.pntd.0003598.
Hsieh, M. H., Brotherton, J. M., & Siddiqui, A. A. (2015). Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?. PLoS neglected tropical diseases, 9(5), e0003598. https://doi.org/10.1371/journal.pntd.0003598
Hsieh, Michael H, et al. "Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?." PLoS neglected tropical diseases vol. 9,5 (2015): e0003598. doi: https://doi.org/10.1371/journal.pntd.0003598
Hsieh MH, Brotherton JM, Siddiqui AA. Hepatitis B Vaccines and HPV Vaccines Have Been Hailed as Major Public Health Achievements in Preventing Cancer--Could a Schistosomiasis Vaccine be the Third?. PLoS Negl Trop Dis. 2015 May 28;9(5):e0003598. doi: 10.1371/journal.pntd.0003598. eCollection 2015 May. PMID: 26020953; PMCID: PMC4447425.
Copy Download .nbib Format: NLM
Post-vaccination myositis and myocarditis in a previously healthy male.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology

Cheng MP, Kozoriz MG, Ahmadi AA, Kelsall J, Paquette K, Onrot JM.
PMID: 26877725
Allergy Asthma Clin Immunol. 2016 Feb 11;12:6. doi: 10.1186/s13223-016-0114-4. eCollection 2016.

BACKGROUND: The immunological literature has been redefining clinical phenomena as hypotheses emerge regarding causal links between triggers, immunologic manifestations, and their specific inflammatory cascades. Of late, autoimmune manifestations that appear to be caused by an external adjuvant have been...

Cite
Cheng MP, Kozoriz MG, Ahmadi AA, et al. Post-vaccination myositis and myocarditis in a previously healthy male. Allergy Asthma Clin Immunol. 2016;12:6doi: 10.1186/s13223-016-0114-4.
Cheng, M. P., Kozoriz, M. G., Ahmadi, A. A., Kelsall, J., Paquette, K., & Onrot, J. M. (2016). Post-vaccination myositis and myocarditis in a previously healthy male. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 126. https://doi.org/10.1186/s13223-016-0114-4
Cheng, Matthew P, et al. "Post-vaccination myositis and myocarditis in a previously healthy male." Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology vol. 12 (2016): 6. doi: https://doi.org/10.1186/s13223-016-0114-4
Cheng MP, Kozoriz MG, Ahmadi AA, Kelsall J, Paquette K, Onrot JM. Post-vaccination myositis and myocarditis in a previously healthy male. Allergy Asthma Clin Immunol. 2016 Feb 11;12:6. doi: 10.1186/s13223-016-0114-4. eCollection 2016. PMID: 26877725; PMCID: PMC4751718.
Copy Download .nbib Format: NLM
Effectiveness of various nonpharmacological analgesic methods in newborns.

Clinical and experimental pediatrics

Kumar P, Sharma R, Rathour S, Karol S, Karol M.
PMID: 31431605
Clin Exp Pediatr. 2020 Jan;63(1):25-29. doi: 10.3345/kjp.2017.05841. Epub 2019 Aug 16.

BACKGROUND: Pain during the developmental period may adversely affect developing neuronal pathways and result in adverse neurodevelopmental, cognitive, and behavioral effects in later life. Immunizations, e.g., hepatitis B vaccine (HBV), administered at birth are painful experiences to which neonates...

Cite
Kumar P, Sharma R, Rathour S, et al. Effectiveness of various nonpharmacological analgesic methods in newborns. Clin Exp Pediatr. 2019;63(1):25-29doi: 10.3345/kjp.2017.05841.
Kumar, P., Sharma, R., Rathour, S., Karol, S., & Karol, M. (2020). Effectiveness of various nonpharmacological analgesic methods in newborns. Clinical and experimental pediatrics, 63(1), 25-29. https://doi.org/10.3345/kjp.2017.05841
Kumar, Pancham, et al. "Effectiveness of various nonpharmacological analgesic methods in newborns." Clinical and experimental pediatrics vol. 63,1 (2020): 25-29. doi: https://doi.org/10.3345/kjp.2017.05841
Kumar P, Sharma R, Rathour S, Karol S, Karol M. Effectiveness of various nonpharmacological analgesic methods in newborns. Clin Exp Pediatr. 2020 Jan;63(1):25-29. doi: 10.3345/kjp.2017.05841. Epub 2019 Aug 16. PMID: 31431605; PMCID: PMC7027346.
Copy Download .nbib Format: NLM
Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study.

Diabetes & metabolic syndrome

Kabir A, Lotfi S, Farsi F, Pazouki A.
PMID: 34450550
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102254. doi: 10.1016/j.dsx.2021.102254. Epub 2021 Aug 22.

AIMS: Hepatitis B virus (HBV) immunization is regarded as the most effective method for the prevention of HBV infection. Various factors, including body mass index (BMI), may contribute to decreased immunization responses. This study aimed to investigate the relationship...

Cite
Kabir A, Lotfi S, Farsi F, et al. Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study. Diabetes Metab Syndr. 2021;15(5):102254doi: 10.1016/j.dsx.2021.102254.
Kabir, A., Lotfi, S., Farsi, F., & Pazouki, A. (2021). Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study. Diabetes & metabolic syndrome, 15(5), 102254. https://doi.org/10.1016/j.dsx.2021.102254
Kabir, Ali, et al. "Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study." Diabetes & metabolic syndrome vol. 15,5 (2021): 102254. doi: https://doi.org/10.1016/j.dsx.2021.102254
Kabir A, Lotfi S, Farsi F, Pazouki A. Impact of body mass index on immunogenicity of hepatitis B vaccine in bariatric surgery candidates: A retrospective study. Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102254. doi: 10.1016/j.dsx.2021.102254. Epub 2021 Aug 22. PMID: 34450550.
Copy Download .nbib Format: NLM
Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.

North American journal of medical sciences

Geier DA, Kern JK, Homme KG, Sykes LK, Geier MR.
PMID: 27583238
N Am J Med Sci. 2016 Jul;8(7):297-306. doi: 10.4103/1947-2714.187148.

BACKGROUND: Obesity among children and adolescents in the United States has tripled since 1980, and has become a major public health concern.AIMS: The purpose of this study was to evaluate the potential relationship between exposure to organic mercury from...

Cite
Geier DA, Kern JK, Homme KG, et al. Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink. N Am J Med Sci. 2016;8(7):297-306doi: 10.4103/1947-2714.187148.
Geier, D. A., Kern, J. K., Homme, K. G., Sykes, L. K., & Geier, M. R. (2016). Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink. North American journal of medical sciences, 8(7), 297-306. https://doi.org/10.4103/1947-2714.187148
Geier, David A, et al. "Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink." North American journal of medical sciences vol. 8,7 (2016): 297-306. doi: https://doi.org/10.4103/1947-2714.187148
Geier DA, Kern JK, Homme KG, Sykes LK, Geier MR. Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink. N Am J Med Sci. 2016 Jul;8(7):297-306. doi: 10.4103/1947-2714.187148. PMID: 27583238; PMCID: PMC4982359.
Copy Download .nbib Format: NLM
Are healthcare workers immunized after receiving hepatitis B vaccination according to recommended guidelines? A systematic review and meta-analysis.

International journal of health sciences

de Geus JL, Koch LFA, Kintopp C, Spada PP, Baratto SP, Giovanini AF, Pizzatto E, Wambier LM.
PMID: 33456441
Int J Health Sci (Qassim). 2021 Jan-Feb;15(1):35-42.

OBJECTIVES: Nowadays, it is believed that more than 240 million people worldwide are infected with the hepatitis B virus (HBV), associated with irreversible health-related consequences, represented by hepatic failure, cirrhosis, and hepatocellular carcinoma, and already are ranked as 15METHODS:...

Cite
de Geus JL, Koch LFA, Kintopp C, et al. Are healthcare workers immunized after receiving hepatitis B vaccination according to recommended guidelines? A systematic review and meta-analysis. Int J Health Sci (Qassim). 2021;15(1):35-42
de Geus, J. L., Koch, L. F. A., Kintopp, C., Spada, P. P., Baratto, S. P., Giovanini, A. F., Pizzatto, E., & Wambier, L. M. (2021). Are healthcare workers immunized after receiving hepatitis B vaccination according to recommended guidelines? A systematic review and meta-analysis. International journal of health sciences, 15(1), 35-42.
de Geus, Juliana Larocca, et al. "Are healthcare workers immunized after receiving hepatitis B vaccination according to recommended guidelines? A systematic review and meta-analysis." International journal of health sciences vol. 15,1 (2021): 35-42.
de Geus JL, Koch LFA, Kintopp C, Spada PP, Baratto SP, Giovanini AF, Pizzatto E, Wambier LM. Are healthcare workers immunized after receiving hepatitis B vaccination according to recommended guidelines? A systematic review and meta-analysis. Int J Health Sci (Qassim). 2021 Jan-Feb;15(1):35-42. PMID: 33456441; PMCID: PMC7786443.
Copy Download .nbib Format: NLM
A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants.

Clinical and experimental vaccine research

Esteghamati A, Sayyahfar S, Ghaemi H, Joulani M, Moradi Y, Talebi A.
PMID: 33628754
Clin Exp Vaccine Res. 2021 Jan;10(1):47-51. doi: 10.7774/cevr.2021.10.1.47. Epub 2021 Jan 31.

PURPOSE: The aim of this study was to compare the hepatitis B surface antibody (HBs Ab) titer 1 month after the 4th dose of hepatitis B vaccine administration on the large and appropriate for gestational age infants.MATERIALS AND METHODS:...

Cite
Esteghamati A, Sayyahfar S, Ghaemi H, et al. A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants. Clin Exp Vaccine Res. 2021;10(1):47-51doi: 10.7774/cevr.2021.10.1.47.
Esteghamati, A., Sayyahfar, S., Ghaemi, H., Joulani, M., Moradi, Y., & Talebi, A. (2021). A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants. Clinical and experimental vaccine research, 10(1), 47-51. https://doi.org/10.7774/cevr.2021.10.1.47
Esteghamati, Abdoulreza, et al. "A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants." Clinical and experimental vaccine research vol. 10,1 (2021): 47-51. doi: https://doi.org/10.7774/cevr.2021.10.1.47
Esteghamati A, Sayyahfar S, Ghaemi H, Joulani M, Moradi Y, Talebi A. A comparison of post vaccination hepatitis B surface antibody level on the large and appropriate for gestational age infants. Clin Exp Vaccine Res. 2021 Jan;10(1):47-51. doi: 10.7774/cevr.2021.10.1.47. Epub 2021 Jan 31. PMID: 33628754; PMCID: PMC7892941.
Copy Download .nbib Format: NLM
Vaccinations and inflammatory bowel disease - a systematic review.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Chan W, Salazar E, Lim TG, Ong WC, Shim HH.
PMID: 33994128
Dig Liver Dis. 2021 Sep;53(9):1079-1088. doi: 10.1016/j.dld.2021.04.015. Epub 2021 May 11.

INTRODUCTION: Patients with inflammatory bowel disease(IBD) are at risk of infections, many of which are preventable with vaccinations. We performed a systematic review on various aspects of vaccination in IBD.METHODS: We searched PubMed, and EMBASE databases, through 31 January...

Cite
Chan W, Salazar E, Lim TG, et al. Vaccinations and inflammatory bowel disease - a systematic review. Dig Liver Dis. 2021;53(9):1079-1088doi: 10.1016/j.dld.2021.04.015.
Chan, W., Salazar, E., Lim, T. G., Ong, W. C., & Shim, H. H. (2021). Vaccinations and inflammatory bowel disease - a systematic review. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53(9), 1079-1088. https://doi.org/10.1016/j.dld.2021.04.015
Chan, Webber, et al. "Vaccinations and inflammatory bowel disease - a systematic review." Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver vol. 53,9 (2021): 1079-1088. doi: https://doi.org/10.1016/j.dld.2021.04.015
Chan W, Salazar E, Lim TG, Ong WC, Shim HH. Vaccinations and inflammatory bowel disease - a systematic review. Dig Liver Dis. 2021 Sep;53(9):1079-1088. doi: 10.1016/j.dld.2021.04.015. Epub 2021 May 11. PMID: 33994128.
Copy Download .nbib Format: NLM
Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B.

Mayo Clinic proceedings. Innovations, quality & outcomes

Corsini Campioli C, Esquer Garrigos Z, Assi M, Go JR, Razonable RR, Beam E, Yao J, Cummins NW.
PMID: 34195546
Mayo Clin Proc Innov Qual Outcomes. 2021 Jan 24;5(3):542-547. doi: 10.1016/j.mayocpiqo.2020.10.010. eCollection 2021 Jun.

OBJECTIVE: To delineate the rate and duration of transient hepatitis B surface antigenemia following Heplisav-B vaccination.PATIENTS AND METHODS: We retrospectively reviewed the medical records of all adult patients who received Heplisav-B vaccination at our institution from January 1, 2019,...

Cite
Corsini Campioli C, Esquer Garrigos Z, Assi M, et al. Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B. Mayo Clin Proc Innov Qual Outcomes. 2021;5(3):542-547doi: 10.1016/j.mayocpiqo.2020.10.010.
Corsini Campioli, C., Esquer Garrigos, Z., Assi, M., Go, J. R., Razonable, R. R., Beam, E., Yao, J., & Cummins, N. W. (2021). Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B. Mayo Clinic proceedings. Innovations, quality & outcomes, 5(3), 542-547. https://doi.org/10.1016/j.mayocpiqo.2020.10.010
Corsini Campioli, Cristina, et al. "Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B." Mayo Clinic proceedings. Innovations, quality & outcomes vol. 5,3 (2021): 542-547. doi: https://doi.org/10.1016/j.mayocpiqo.2020.10.010
Corsini Campioli C, Esquer Garrigos Z, Assi M, Go JR, Razonable RR, Beam E, Yao J, Cummins NW. Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B. Mayo Clin Proc Innov Qual Outcomes. 2021 Jan 24;5(3):542-547. doi: 10.1016/j.mayocpiqo.2020.10.010. eCollection 2021 Jun. PMID: 34195546; PMCID: PMC8240146.
Copy Download .nbib Format: NLM
Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines.

Scientific reports

Nishida N, Sugiyama M, Ohashi J, Kawai Y, Khor SS, Nishina S, Yamasaki K, Yazaki H, Okudera K, Tamori A, Eguchi Y, Sakai A, Kakisaka K, Sawai H, Tsuchiura T, Ishikawa M, Hino K, Sumazaki R, Takikawa Y, Kanda T, Yokosuka O, Yatsuhashi H, Tokunaga K, Mizokami M.
PMID: 33654122
Sci Rep. 2021 Mar 02;11(1):3703. doi: 10.1038/s41598-021-82986-8.

Hepatitis B (HB) vaccines (Heptavax-II and Bimmugen) designed based on HBV genotypes A and C are mainly used for vaccination against HB in Japan. To determine whether there are differences in the genetic background associated with vaccine responsiveness, genome-wide...

Cite
Nishida N, Sugiyama M, Ohashi J, et al. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci Rep. 2021;11(1):3703doi: 10.1038/s41598-021-82986-8.
Nishida, N., Sugiyama, M., Ohashi, J., Kawai, Y., Khor, S. S., Nishina, S., Yamasaki, K., Yazaki, H., Okudera, K., Tamori, A., Eguchi, Y., Sakai, A., Kakisaka, K., Sawai, H., Tsuchiura, T., Ishikawa, M., Hino, K., Sumazaki, R., Takikawa, Y., Kanda, T., Yokosuka, O., Yatsuhashi, H., Tokunaga, K., & Mizokami, M. (2021). Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Scientific reports, 11(1), 3703. https://doi.org/10.1038/s41598-021-82986-8
Nishida, Nao, et al. "Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines." Scientific reports vol. 11,1 (2021): 3703. doi: https://doi.org/10.1038/s41598-021-82986-8
Nishida N, Sugiyama M, Ohashi J, Kawai Y, Khor SS, Nishina S, Yamasaki K, Yazaki H, Okudera K, Tamori A, Eguchi Y, Sakai A, Kakisaka K, Sawai H, Tsuchiura T, Ishikawa M, Hino K, Sumazaki R, Takikawa Y, Kanda T, Yokosuka O, Yatsuhashi H, Tokunaga K, Mizokami M. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines. Sci Rep. 2021 Mar 02;11(1):3703. doi: 10.1038/s41598-021-82986-8. PMID: 33654122; PMCID: PMC7925550.
Copy Download .nbib Format: NLM
Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization.

World journal of gastroenterology

Li H, Li RC, Liao SS, Yang JY, Zeng XJ, Wang SS.
PMID: 11819352
World J Gastroenterol. 1998 Dec;4(6):493-496. doi: 10.3748/wjg.v4.i6.493.

AIM:To identify the persistence of immune protection of China-made, plasma derived hepatitis B vaccine after infancy immunization and the time table of booster immunization.METHODS:A cross-sectional follow-up study and an experimental study on booster were used for the evaluation of...

Cite
Li H, Li RC, Liao SS, et al. Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World J Gastroenterol. 1998;4(6):493-496doi: 10.3748/wjg.v4.i6.493.
Li, H., Li, R. C., Liao, S. S., Yang, J. Y., Zeng, X. J., & Wang, S. S. (1998). Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World journal of gastroenterology, 4(6), 493-496. https://doi.org/10.3748/wjg.v4.i6.493
Li, Hui, et al. "Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization." World journal of gastroenterology vol. 4,6 (1998): 493-496. doi: https://doi.org/10.3748/wjg.v4.i6.493
Li H, Li RC, Liao SS, Yang JY, Zeng XJ, Wang SS. Persistence of hepatitis B vaccine immune protection and response to hepatitis B booster immunization. World J Gastroenterol. 1998 Dec;4(6):493-496. doi: 10.3748/wjg.v4.i6.493. PMID: 11819352; PMCID: PMC4723436.
Copy Download .nbib Format: NLM
Recent Advances and New Challenges in Travel Medicine.

Current infectious disease reports

Chen LH, Wilson ME.
PMID: 11853657
Curr Infect Dis Rep. 2002 Feb;4(1):50-58. doi: 10.1007/s11908-002-0067-2.

Recent advances in travel medicine include the use of computer resources to obtain information on outbreaks and recommendations to travelers, the introduction of atovaquone/proguanil as chemoprophylaxis and treatment for malaria, the use of azithromycin as an alternative in the...

Cite
Chen LH, Wilson ME. Recent Advances and New Challenges in Travel Medicine. Curr Infect Dis Rep. 2002;4(1):50-58doi: 10.1007/s11908-002-0067-2.
Chen, L. H., & Wilson, M. E. (2002). Recent Advances and New Challenges in Travel Medicine. Current infectious disease reports, 4(1), 50-58. https://doi.org/10.1007/s11908-002-0067-2
Chen, Lin H., and Wilson, Mary E.. "Recent Advances and New Challenges in Travel Medicine." Current infectious disease reports vol. 4,1 (2002): 50-58. doi: https://doi.org/10.1007/s11908-002-0067-2
Chen LH, Wilson ME. Recent Advances and New Challenges in Travel Medicine. Curr Infect Dis Rep. 2002 Feb;4(1):50-58. doi: 10.1007/s11908-002-0067-2. PMID: 11853657.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 59 entries